Phosphagenics Limited
ASX:POH ISIN:AU000000POH7
Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.
Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC.
Noticias
El Reporte del Mercado Australiano del 7 de febrero de 2011 incluye: Automotive Technology Group Limited (ASX:ATJ) anunció que el Sprintex(R) Supercharger de la compañía es el sistema de compresión automovilístico mas eficiente del mundo; Estudios de carbón resalta potencial para la exportación de carbón térmico del proyecto Mmamantswe de Aviva Corporation Limited (ASX:AVA) en Bostwana; EnviroGold Limited (ASX:EVG) ha reforzado significativamente su gestión en América Latina; Phosphagenics Limited (ASX:POH) anunció colaboración para desarrollar droga para la psoriasis en Estados Unidos de América.
90,109 Visitas al Perfil de la Empresa
- Número de visitas: (Últimos 7 Días: 8) (Últimos 30 Días: 51) (Desde su Publicación: 7152)